Hit enter to search or ESC to close

Home
Healthcare Professionals
Patient Support
- Women’s Health
- Men’s Health
About
Reporting
Contact Us

Besins Briefing Sessions

Prescribing for perimenopause and menopause – Dr Kelly Teagle and Dr Lynda Newman

Prescribing for perimenopause and menopause – Dr Kelly Teagle and Dr Lynda Newman

Expert Panel: Menopause Management Past, Present, Future

Besins Briefing Sessions

Expert Panel: Menopause Management Past, Present, Future

Prof. Bronwyn Stuckey – Breast Cancer Risk with MHT for Low-risk and High-risk Women

Besins Briefing Sessions

Prof. Bronwyn Stuckey – Breast Cancer Risk with MHT for Low-risk and High-risk Women

Prof. Rod Baber: RANZCOG 2021 MHT Masterclass

Besins Briefing Sessions

Prof. Rod Baber: RANZCOG 2021 MHT Masterclass

Dr Sonia Davison – The latest evidence in menopause management

Besins Briefing Sessions

Dr Sonia Davison – The latest evidence in menopause management

Dr. Terri Foran – Counselling and the menopause: How effective is MHT?

Besins Briefing Sessions

Dr. Terri Foran – Counselling and the menopause: How effective is MHT?

Prof. Rod Baber – MHT and its impact on the brain

Besins Briefing Sessions

Prof. Rod Baber – MHT and its impact on the brain

Prof. Susan Davis Cardiometabolic benefits of MHT

Besins Briefing Sessions

Prof. Susan Davis Cardiometabolic benefits of MHT

Dr. Terri Foran Practical advice for prescribing MHT

Besins Briefing Sessions

Dr. Terri Foran Practical advice for prescribing MHT

Prof Rod Baber. Modern MHT: maximising benefits and minimising risks

Besins Briefing Sessions

Prof Rod Baber. Modern MHT: maximising benefits and minimising risks

Quick Links

Healthcare Professionals

Patients

Reporting of payments

About Us

Women’s Health

Men’s Health

Contact Info

Suite 5.02, 12 Help St Chatswood,
NSW 2067, Australia

Office Phone : 02 9904 7473

Medical Information: 1800 BESINS
(1800 237 467)

© 2023 Besins Healthcare | Privacy Policy | Legal Notice
Besins Healthcare Australia Pty Ltd ABN 68 164 882 062 Androgel^®, Estrogel^®, Prometrium^®, Testogel^®, Utrogestan^® are registered trademarks of Besins Healthcare. Slinda^® is a registered trademark of Chemo Research S.L.

Close Menu

Home
Healthcare Professionals
Patient Support
- Women’s Health
- Men’s Health
About
Reporting
Contact Us

Subscribe to Besins Briefing Series

Name

Practice Name

State

Leave this field empty if you're human:

Medical Information for Patients and Healthcare Professionals

Phone 1800 BESINS (1800 237 467) to report any information regarding adverse events or product complaints.

medinfo.au@besins-healthcare.com

Subscribe to Besins Updates on the Prevention of Preterm Birth

* indicates required

Email Address *

First Name

Last Name

Practice Name *

AHPRA Number *

State *

Request a call from a representative

Privacy Statement
Besins Healthcare Australia Pty Limited is bound by the Privacy Act 1988 (Cth) and adheres to the Australian Privacy Principles in relation to collecting, holding, using, disclosing, securing, and allowing access to your personal information. Besins may collect and hold personal information related to you which is necessary to conduct our business. You are not obliged to provide the information and you may choose not to. If you do not provide the information, Besins may not be able to provide support to you effectively or at all. If you would like to access, update, or correct your personal information or if you do not want your personal information retained on the database, please contact the Privacy Officer via Phone: (02) 9904 7473, Fax: (02) 9411 3475, or Email: privacy.au@besins-healthcare.com. A copy of our complete privacy policy is available on our website: besins-healthcare.com.au/privacy-policy. If you no longer wish to receive information please mail or fax to Besins Healthcare. The personal information you provide on this form will only be used to supply you with the product samples and product information you have requested.

Utrogestan

We are a world leader in novel therapies for gynaecology and andrology. We have discovered ground-breaking technologies to improve patient well-being throughout our history. We developed several hormone therapies over the years including bioavailable natural progesterone which can be delivered by different routes of administration and a natural testosterone transdermal gel for testosterone deficiency syndrome. We continue to be a leader in estradiol replacement therapy with the first transdermal gel marketed in Europe.

We are a world leader in novel therapies for gynaecology and andrology. We have discovered ground-breaking technologies to improve patient well-being throughout our history.

Our Spring Sale Has Started

You can see how this popup was set up in our step-by-step guide: https://wppopupmaker.com/guides/auto-opening-announcement-popups/

MEDICAL ENQUIRY

REQUEST A REP

Please note you are now leaving the Besins Australia website.

Continue

Besins Briefing Sessions

Prescribing for perimenopause and menopause – Dr Kelly Teagle and Dr Lynda Newman

Expert Panel: Menopause Management Past, Present, Future

Prof. Bronwyn Stuckey – Breast Cancer Risk with MHT for Low-risk and High-risk Women

Prof. Rod Baber: RANZCOG 2021 MHT Masterclass

Dr Sonia Davison – The latest evidence in menopause management

Dr. Terri Foran – Counselling and the menopause: How effective is MHT?

Prof. Rod Baber – MHT and its impact on the brain

Prof. Susan Davis Cardiometabolic benefits of MHT

Dr. Terri Foran Practical advice for prescribing MHT

Prof Rod Baber. Modern MHT: maximising benefits and minimising risks

Recent Posts

Recent Comments

Quick Links

About Us

Contact Info

Medical Information for Patients and Healthcare Professionals